查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514919

性传染病诊断市场，按疾病类型、诊断测试类型、设备、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Sexually Transmitted Disease Diagnostics Market, By Disease Type, By Diagnostic Test Type, By Device, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 366 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年，性传染病诊断市场规模为 923.4534 亿美元，2024 年至 2032 年复合年增长率为 5.5%。

性传染病诊断市场-市场动态

性传染病盛行率的上升以及护理点 (POC) 等诊断技术的进步预计将推动市场需求

全球性病患病率的增加极大地推动了性病诊断市场的发展。性传染病的传播受到多种因素的促进，包括性行为的改变、医疗保健的取得困难和意识低落。对诊断测试的需求是由鼓励对性传染病进行常规筛检的公共卫生努力和宣传活动所推动的。当努力减少检测和治疗带来的耻辱时，人们也更有可能寻求检测服务。透过支持研究、实施筛检计画以及为诊断检测提供财政援助，政府实体和非营利组织经常支持性病预防和控制措施。这种支援使测试服务更容易获得，从而推动市场扩张。

快速诊断检测 (RDT)、即时检测 (POCT) 和核酸扩增检测 (NAAT) 等诊断技术的发展提高了 STD 诊断的准确性、速度和可近性。分子诊断的自动化和进步进一步提高了测试程序的有效性。由于向分散式测试的转变，特别是在资源有限或偏远地区的环境中，对即时测试解决方案的需求很高。便携式、使用者友善的诊断设备可以实现快速诊断和及时治疗，这对于阻止性传染病的传播至关重要。

性传染病诊断市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 5.5% 左右的复合年增长率成长

根据疾病类型细分，由于爱滋病毒感染的流行，预计爱滋病毒/爱滋病细分市场将在 2023 年显示最大的市场份额。

根据诊断测试类型细分，由于实验室测试大量采用新技术，实验室测试细分市场将成为 2023 年领先的诊断测试类型。

根据设备细分，由于实验室测试设备的高需求，实验室设备细分市场是 2023 年的领先设备。

按地区划分，由于先进的医疗保健解决方案的存在，北美在 2023 年成为领先的收入来源。

性传染病诊断市场-細項分析：

全球性传染病诊断市场根据疾病类型、诊断测试类型、设备和地区进行细分。

依疾病类型，市场分为六类：披衣菌、淋病、梅毒、生殖器疱疹、B型肝炎和爱滋病毒/爱滋病。爱滋病毒/爱滋病细分市场占据主导地位。梅毒、淋病的日益普及也推动了市场的成长。

根据诊断测试类型，市场分为两类：实验室测试和护理点测试。实验室测试领域主导市场。据估计，护理点测试在预测期内将以最快的复合年增长率成长。

市场依设备分为两类：实验室设备和POC设备。实验室设备领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。对血液测试和其他身体测试设备的高需求正在促进该细分市场的成长。

性传染病诊断市场 - 地理洞察

在全球范围内，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。北美是性传染病诊断的主要市场。在亚太地区，医疗保健支出的增加，特别是在中国、印度等新兴经济体，有助于性病诊断市场的扩张。增加对实验室和检测设施等医疗基础设施的投资，可以改善获得诊断服务的机会。

性传染病诊断市场-竞争格局：

性传染病诊断市场适度整合。市场参与者参与技术创新、开发和合作等策略活动，以扩大其产品和服务组合併涵盖全球。诊断公司、医疗保健提供者和公共卫生机构之间的合作促进了创新诊断解决方案的开发和部署。合作伙伴关係还可以帮助扩大市场范围并改善分销管道。

最近的发展：

2022 年5 月，经欧盟委员会批准，Qiagen Inc. 推出了NeuMoDxHSV 1/2 Quant Assay，用于对1 型单纯疱疹病毒(HSV-1) DNA 和/或2 型单纯疱疹病毒(HSV-2) 进行定量和区分。

2022 年 5 月，美国食品药物管理局批准了 Abbott 的 Alinity m STI Assay 用于治疗性传染感染。

目录

第一章：性传染病诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按疾病类型分類的性传染病诊断市场片段
    • 按诊断测试类型分類的性传染病诊断市场片段
    • 按设备分類的性传染病诊断市场片段
    • 按国家/地区分類的性传染病诊断市场片段
    • 按地区分類的性传染病诊断市场片段
  • 竞争洞察

第 3 章：性传染病诊断主要市场趋势

  • 性传染病诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 性传染病诊断市场限制
    • 市场限制影响分析
  • 性传染病诊断市场机会
  • 性传染病诊断市场未来趋势

第 4 章：性传染病诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：性传染病诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：性传染病诊断市场格局

  • 2024 年性传染病诊断市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：性传染病诊断市场 - 按疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 衣原体
    • 淋病
    • 梅毒
    • 生殖器疱疹
    • B型肝炎
    • HIV爱滋病

第 8 章：性传染病诊断市场 - 按诊断测试类型

  • 概述
    • 按诊断测试类型分類的细分市场份额分析
    • 实验室测试
    • 护理点测试

第 9 章：性传染病诊断市场 - 按设备

  • 概述
    • 按设备分類的细分市场占有率分析
    • 实验室设备
    • 护理点设备

第 10 章：性传染病诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美性传染病诊断主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疾病类型）
    • 北美市场规模和预测（按诊断测试类型）
    • 北美市场规模和预测（按设备）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲性传染病诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按疾病类型）
    • 欧洲市场规模和预测（按诊断测试类型）
    • 欧洲市场规模与预测（按设备）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区性传染病诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按疾病类型）
    • 亚太地区市场规模和预测（按诊断测试类型）
    • 亚太地区市场规模与预测（按设备）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲性传染病诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 拉丁美洲市场规模和预测（按诊断测试类型）
    • 拉丁美洲市场规模与预测（按设备）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲性传染病诊断主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 中东和非洲市场规模和预测（按诊断测试类型）
    • 中东和非洲市场规模及预测（按设备）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 性传染病诊断产业

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • Becton, Dickinson and Company (BD)
    • Roche Diagnostics
    • Cepheid
    • Hologic, Inc.
    • bioMerieux
    • Siemens Healthineers
    • QIAGEN Inc.
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories
    • GenMark Diagnostics
    • OraSure Technologies
    • Mylan NV
    • Alere Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3033

REPORT HIGHLIGHT

Sexually Transmitted Disease Diagnostics Market size was valued at USD 92,345.34 Million in 2023, expanding at a CAGR of 5.5% from 2024 to 2032.

Diagnostics for sexually transmitted diseases (STDs) are the several techniques and examinations used to find out if a person has a sexually transmitted infection (STI). These tests are essential for the early diagnosis, management, and control of sexually transmitted infections.

Sexually Transmitted Disease Diagnostics Market- Market Dynamics

Rising prevalence of STDs and advancement in diagnostics technologies like Point of Care (POCs) are expected to propel market demand

The market for STD diagnostics is significantly driven by the increased prevalence of STDs across the globe. The transmission of sexually transmitted diseases is facilitated by several factors, including altered sexual behavior, poor access to healthcare, and low awareness. The need for diagnostic testing is driven by public health efforts and awareness campaigns that encourage routine screening for sexually transmitted diseases. People are also more likely to seek testing services when efforts are made to lessen the stigma attached to testing and treatment. Through supporting research, putting screening programs into place, and providing financial assistance for diagnostic testing, government entities and non-profit groups frequently support STD prevention and control measures. This support makes testing services more accessible, which propels market expansion.

The accuracy, speed, and accessibility of STD diagnostics have been enhanced by developments in diagnostic technologies, such as rapid diagnostic tests (RDTs), point-of-care testing (POCTs), and nucleic acid amplification tests (NAATs). Automation and advances in molecular diagnostics increase the effectiveness of testing procedures even more. Point-of-care testing solutions are in high demand due to the shift towards decentralized testing, especially in settings with limited resources or remote locations. Rapid diagnosis and prompt treatment are made possible by portable, user-friendly diagnostic equipment, which is essential for halting the spread of STDs.

Sexually Transmitted Disease Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2024-2032)

Based on Disease Type segmentation, the HIV/AIDS segment was predicted to show maximum market share in the year 2023, owing to the prevalence of HIV infections.

Based on Diagnostic Test Type segmentation, the laboratory testing segment was the leading Diagnostic Test Type in 2023, due to the high adoption of new tech at laboratory testing.

Based on Device segmentation, the laboratory devices segment was the leading Device in 2023, owing to the high demand for laboratory testing devices.

Based on region, North America was the leading revenue generator in 2023, owing to the presence of advanced healthcare solutions.

Sexually Transmitted Disease Diagnostics Market- Segmentation Analysis:

The Global Sexually Transmitted Disease Diagnostics Market is segmented based on Disease Type, Diagnostic Test Type, Device, and Region.

The market is divided into six categories based on Disease Type: Chlamydia, Gonorrhea, Syphilis, Genital herpes, Hepatitis B, and HIV/AIDS. The HIV/AIDS segment dominates the market. The growing prevalence of syphilis, gonorrhea, is also boosting the market growth.

The market is divided into two categories based on the Diagnostic Test Type: laboratory test and point of care testing. The laboratory testing segment dominates the market. The point of care testing is estimated to grow at the fastest CAGR over the forecast period.

The market is divided into two categories based on Device: laboratory devices and POC devices. The laboratory devices segment dominates the market and is expected to maintain its high dominance during the forecast period. High demand for blood tests, and other body testing devices are augmenting the segment growth.

Sexually Transmitted Disease Diagnostics Market- Geographical Insights

Globally, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is a dominating market for Sexually Transmitted Disease Diagnostics. In Asia Pacific, the increasing healthcare spending, particularly in emerging economies like China, India, contributes to the expansion of the STD diagnostics market. Greater investment in healthcare infrastructure, including laboratories and testing facilities, improves access to diagnostic services.

Sexually Transmitted Disease Diagnostics Market- Competitive Landscape:

The sexually transmitted disease diagnostics market is moderately consolidated. Market players are involved in strategic activities like technology innovation, development, and partnerships to expand their product & service portfolio and reach across the globe. Collaboration between diagnostic companies, healthcare providers, and public health agencies facilitates the development and deployment of innovative diagnostic solutions. Partnerships can also help expand market reach and improve distribution channels.

Recent Developments:

In May 2022, Qiagen Inc. introduced NeuMoDxHSV 1/2 Quant Assay for the quantification and differentiation of herpes simplex virus type 1 (HSV-1) DNA and/or herpes simplex virus type 2 (HSV-2) with approval from the European Commission.

In May 2022, The Food and Drug Administration approved Abbott's Alinity m STI Assay for STIs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET KEY PLAYERS

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • Roche Diagnostics
  • Cepheid
  • Hologic, Inc.
  • bioMerieux
  • Siemens Healthineers
  • QIAGEN Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • GenMark Diagnostics
  • OraSure Technologies
  • Mylan N.V.
  • Alere Inc.
  • Others

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Chlamydia
  • Gonorrhea
  • Syphilis
  • Genital herpes
  • Hepatitis B
  • HIV/AIDS

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TEST TYPE- MARKET ANALYSIS, 2019-2032

  • Laboratory Testing
  • Point Of Care Testing

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY DEVICE- MARKET ANALYSIS, 2019-2032

  • Laboratory Devices
  • Point of Care Devices

GLOBAL SEXUALLY TRANSMITTED DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sexually Transmitted Disease Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sexually Transmitted Disease Diagnostics Market Snippet by Disease Type
    • 2.1.2. Sexually Transmitted Disease Diagnostics Market Snippet by Diagnostic Test Type
    • 2.1.3. Sexually Transmitted Disease Diagnostics Market Snippet by Device
    • 2.1.4. Sexually Transmitted Disease Diagnostics Market Snippet by Country
    • 2.1.5. Sexually Transmitted Disease Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Sexually Transmitted Disease Diagnostics Key Market Trends

  • 3.1. Sexually Transmitted Disease Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sexually Transmitted Disease Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sexually Transmitted Disease Diagnostics Market Opportunities
  • 3.4. Sexually Transmitted Disease Diagnostics Market Future Trends

4. Sexually Transmitted Disease Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sexually Transmitted Disease Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sexually Transmitted Disease Diagnostics Market Landscape

  • 6.1. Sexually Transmitted Disease Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sexually Transmitted Disease Diagnostics Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 7.1.2. Chlamydia
    • 7.1.3. Gonorrhea
    • 7.1.4. Syphilis
    • 7.1.5. Genital herpes
    • 7.1.6. Hepatitis B
    • 7.1.7. HIV/AIDS

8. Sexually Transmitted Disease Diagnostics Market - By Diagnostic Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnostic Test Type, 2024 & 2032 (%)
    • 8.1.2. Laboratory Testing
    • 8.1.3. Point Of Care Testing

9. Sexually Transmitted Disease Diagnostics Market - By Device

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Device, 2024 & 2032 (%)
    • 9.1.2. Laboratory Devices
    • 9.1.3. Point of Care Devices

10. Sexually Transmitted Disease Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Sexually Transmitted Disease Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostic Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Device, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Sexually Transmitted Disease Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Becton, Dickinson and Company (BD)
    • 11.2.3. Roche Diagnostics
    • 11.2.4. Cepheid
    • 11.2.5. Hologic, Inc.
    • 11.2.6. bioMerieux
    • 11.2.7. Siemens Healthineers
    • 11.2.8. QIAGEN Inc.
    • 11.2.9. Danaher Corporation
    • 11.2.10. Thermo Fisher Scientific
    • 11.2.11. Bio-Rad Laboratories
    • 11.2.12. GenMark Diagnostics
    • 11.2.13. OraSure Technologies
    • 11.2.14. Mylan N.V.
    • 11.2.15. Alere Inc.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sexually Transmitted Disease Diagnostics Market: Disease Type Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Sexually Transmitted Disease Diagnostics Market, by Disease Type 2019-2032 (USD Million)
  • TABLE Sexually Transmitted Disease Diagnostics Market: Diagnostic Test Type Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Diagnostic Test Type
  • TABLE Global Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type 2019-2032 (USD Million)
  • TABLE Sexually Transmitted Disease Diagnostics Market: Device Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Device
  • TABLE Global Sexually Transmitted Disease Diagnostics Market, by Device 2019-2032 (USD Million)
  • TABLE Sexually Transmitted Disease Diagnostics Market: Regional snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sexually Transmitted Disease Diagnostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE North America Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
  • TABLE North America Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)
  • TABLE Europe Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Europe Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
  • TABLE Europe Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)
  • TABLE Latin America Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Latin America Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
  • TABLE Latin America Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sexually Transmitted Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sexually Transmitted Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sexually Transmitted Disease Diagnostics Market, by Diagnostic Test Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sexually Transmitted Disease Diagnostics Market, by Device, 2019-2032 (USD Million)

List of Figures

  • FIGURE Sexually Transmitted Disease Diagnostics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2024
  • FIGURE Disease Type segment market share analysis, 2024 & 2032
  • FIGURE Disease Type segment market size forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Diagnostic Test Type segment market share analysis, 2024 & 2032
  • FIGURE Diagnostic Test Type segment market size forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Device segment market share analysis, 2024 & 2032
  • FIGURE Device segment market size forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2024 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE North America Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
  • FIGURE Europe Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
  • FIGURE Asia Pacific Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
  • FIGURE Latin America Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
  • FIGURE Middle East and Africa Sexually Transmitted Disease Diagnostics Market share and leading players, 2024
  • FIGURE North America market share analysis by country, 2024
  • FIGURE U.S. Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Canada Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Europe Sexually Transmitted Disease Diagnostics Market share analysis by country, 2024
  • FIGURE Germany Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Spain Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Italy Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE France Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE UK Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Russia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Netherlands Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Sweden Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Poland Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Rest of the Europe Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Asia Pacific Sexually Transmitted Disease Diagnostics Market share analysis by country, 2024
  • FIGURE India Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE China Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Japan Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE South Korea Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Australia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Thailand Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Indonesia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Philippines Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Rest of APAC Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Latin America Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Latin America Sexually Transmitted Disease Diagnostics Market share analysis by country, 2024
  • FIGURE Brazil Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Mexico Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Argentina Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Colombia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Rest of LATAM Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Middle East and Africa Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Middle East and Africa Sexually Transmitted Disease Diagnostics Market share analysis by country, 2024
  • FIGURE Saudi Arabia Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE United Arab Emirates Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Israel Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Turkey Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Algeria Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Egypt Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)
  • FIGURE Rest of MEA Sexually Transmitted Disease Diagnostics Market size, forecast and trend analysis, 2018 to 2032 (USD Million)